Weill Cornell Myeloma Center

03/30/2026

Chimeric antigen receptor (CAR) T-cell therapy is another form of cellular that uses a patient’s own immune system to fight . All you need to know, broken down in both English and Spanish: https://bit.ly/3NuSfOh

03/26/2026

Want to find out even more about how bispecific t-cell engager (BiTE) therapy works? This video outlines the process. https://bit.ly/4lPfS74

Bispecific T-Cell engager (BiTE) therapy is a novel immunotherapy approach that helps the body’s immune system target cancer cells. In myeloma, BiTEs have th...

03/24/2026

Listen to Dr. Mateo Mejia on the Weill Cornell Medicine to learn more about how bispecific t-cell engager, or BiTE, therapy works in , including associated side effects and the future of this type of treatment: https://bit.ly/4lH4Kc8

Podcast Episode · CancerCast · March 20 · 1 sec

03/18/2026

Monoclonal proteins, or M proteins, are abnormal antibodies found in the blood of patients with . For , learn more about this protein and what it means in : https://bit.ly/3QT68ZH

03/10/2026

This , we’re sharing information about and related plasma cell disorders. Learn more about this in this video explainer. https://bit.ly/49wtv48

01/23/2026

We’re excited to welcome Dr. Victor Jimenez Zepeda to our team! He’s available for appointments for patients with and : https://bit.ly/4pTV1Qv

01/20/2026

Dr. Mateo Mejia reflected on the “Meaningful Moments in ” panel from at , which brought together patients, advocates and clinicians to share real-world experiences:

Dr. Mateo Mejia shares the importance of connecting with patients outside traditional clinical encounters and how emotional/psychosocial outcomes intersect with clinical outcomes.

12/19/2025

Dr. Mateo Mejia was involved with work recently published by American Society of Clinical Oncology on refining precursors and the risk of progression through genomics:

BRIDGING THE GAPDecember 12, 2025 Share on Bridging the Gap: Refining Myeloma Precursors and Their Risk of Progression Through GenomicsAuthors: Mateo Mejia Saldarriaga, MD https://orcid.org/0000-0002-3504-5597 [email protected], and Polina Bellman, MD https://orcid.org/0000-0003-4616-8821Authors In...

05/09/2025

Our team member Dr. Mateo Mejia is dedicated to caring for patients with . Learn more about his background, , and dedication to giving back via Medscape:

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with treatment-resistant multiple myeloma.

02/19/2025

At the Lymphoma, Leukemia & Myeloma Congress , Dr. Mateo Mejia spoke with Oncology Learning Network about the latest clinical trial data on using CAR T-cell therapies for relapsed/refractory :

Mateo Mejia Saldarriaga, MD discusses the latest trial data on the utilization of various CAR T-cell therapies for patients with relapsed/refractory multiple myeloma at the 2025 Lymphoma, Leukemia & Myeloma Winter Symposium.

02/07/2025

El Dr. Mateo Mejia habló con The Leukemia & Lymphoma Society en su podcast en español sobre que es el mieloma múltiple, como se presenta, y cuáles son los últimos avances en su tratamiento:

En este episodio conocemos al Dr. Mateo Mejia Saldarriaga de Weill Cornell Medicine, hospital NewYork-Presbyterian. Únase para aprender cómo los avances científicos han transformado el tratamiento de mieloma dándole lugar a mejores resultados y pronósticos para pacientes. DESCARGAR TRANSCRIPCI....

10/08/2024

El Dr. Mateo Mejia estará presentando en el evento de The Leukemia & Lymphoma Society sobre la importancia de la comunicación entre el paciente y su equipo médico en el tratamiento para cáncer hematológico. Si estas interesando en conocer más información sobre como navegar el diagnostico de cáncer y algunos de los recursos para la comunidad Latina regístrate en el link: https://msg.lls.org/Oct19

Dr. Mateo Mejia is speaking at a The Leukemia & Lymphoma Society program in Spanish on the importance of communication between patients and their blood cancer care team. Learn about navigating a diagnosis and resources available for the Latino community. Register here: https://msg.lls.org/Oct19